Study guide

Cognitive Development, Attachment, Screening, and Common Emotional Disorders

EBP-EAP Examination in Paediatrics Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding

EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)

2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity

Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol

3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections

Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening

4 Chapter 4: Acute Paediatric Emergencies & Critical Care

EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination

5 Chapter 5: Paediatric Respiratory Medicine

Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations

6 Chapter 6: Paediatric Cardiology

Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever

7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition

Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure

8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance

Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management

9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism

Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)

10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health

Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy

11 Chapter 11: Paediatric Haematology & Oncology

Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia

12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy

Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules

13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions

The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia

14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics

Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics

15 Chapter 15: Paediatric Ophthalmology & ENT Disorders

Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions

16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health

Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance

17 Chapter 17: Adolescent Medicine & Healthcare Transition

Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition

18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics

Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics

19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine

Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy

Cognitive Development, Attachment, Screening, and Common Emotional Disorders

Key Takeaways Explain This Topic AI

Cognitive maturation advances sequentially through Piaget's four discrete stages (sensorimotor, preoperational, concrete operational, formal operational), paralleled by psychosocial development across Erikson's lifespan crises (trust vs mistrust through identity vs role confusion).

Ainsworth's Strange Situation categorizes infant attachment into secure (Type B), insecure-avoidant (Type A), insecure-resistant/ambivalent (Type C), and disorganised (Type D); disorganised attachment strongly correlates with severe neglect, trauma, and profound neuroendocrine HPA axis dysregulation.

Paediatric psychiatric screening utilizes standardized, multi-informant tools—including the Strengths and Difficulties Questionnaire (SDQ: 5 subscales), Pediatric Symptom Checklist (PSC-17/35), PHQ-9A (adolescent depression), and SCARED (childhood anxiety)—to detect hidden emotional and behavioural morbidity.

Depression in children and adolescents may present with irritability, somatic symptoms and academic decline. Offer psychological treatment and specialist review; NICE favours fluoxetine when an antidepressant is indicated, with close monitoring for activation and suicidality.

Suicidal crises, NSSI and acute psychosis require prompt safety assessment and appropriate mental-health care. Take a medical and substance-use history and examine the child; neurological, systemic or toxicological findings guide targeted investigations for organic causes.

Last updated: November 2026

Cognitive Development, Attachment, Screening, and Common Emotional Disorders

Paediatric mental health requires an integrated developmental perspective. Clinical presentations of psychiatric distress in children and adolescents are shaped by neurodevelopmental maturity, attachment relationships, and psychosocial contexts. The paediatrician must distinguish normal developmental variations from emergent psychopathology, deploy validated screening tools, identify affective and anxiety disorders early, and systematically investigate potential organic etiologies in psychiatric emergencies.

Stages of Cognitive and Psychosocial Development

An accurate developmental framework allows clinicians to gauge whether a child's thinking, emotional regulation, and social interactions are age-appropriate or represent developmental delay or psychiatric disturbance. [Piaget: Cognitive Maturation]

  • |
  • +-------------------+-------------+-------------+-------------------+
  • | | | |
  • [Sensorimotor] [Preoperational] [Concrete Operational] [Formal Operational]
  • (0-2 Years) (2-7 Years) (7-11 Years) (11+ Years)
  • Object - Symbolic thought - Conservation - Abstract logic
  • permanence - Egocentrism, Centration - Reversibility - Hypothetical
  • Motor schemas - Magical thinking - Concrete logic deduction
  • Jean Piaget's Stages of Cognitive Development

Sensorimotor Stage (Birth to 2 Years) :

Core Mechanism : Infants experience and interpret the world entirely through sensory perceptions and motor activities (looking, sucking, grasping, manipulating).

Object Permanence : The understanding that objects continue to exist even when out of direct sight. Begins emerging around 8 to 9 months of age (demonstrated by searching for a hidden toy) and is fully consolidated by 18 to 24 months.

Clinical Significance : Coincides with the onset of physiological stranger anxiety (7–9 months) and separation anxiety (peak 12–18 months), which directly rely on the infant remembering the absent caregiver.

Preoperational Stage (2 to 7 Years) :

Core Mechanism : Emergence of symbolic thought, mental representation, and rapid language acquisition, allowing the child to engage in pretend and imaginative play.

Egocentrism : Inability to distinguish one's own perspective from that of others (illustrated by Piaget's "Three Mountain Task"). The child assumes everyone perceives, thinks, and feels exactly as they do.

Centration and Lack of Conservation : The child focuses (centers) on only one salient perceptual dimension of an object while ignoring other crucial attributes. Consequently, they fail tests of conservation (e.g., believing that pouring water into a tall, narrow beaker increases the amount of liquid).

Magical Thinking and Animism : Ascribing lifelike intentions and emotions to inanimate objects (animism), and believing that personal thoughts or minor misbehaviors can cause external real-world events (e.g., a preschooler believing their anger caused a sibling's illness or parents' divorce).

Concrete Operational Stage (7 to 11 Years) :

Core Mechanism : Acquisition of operational, logical thought processes applied strictly to concrete, tangible objects and real-world situations.

Conservation : Mastering the principles of conservation of number, mass, and volume. The child understands reversibility (transformations can be mentally undone) and compensation.

Classification and Seriation : Ability to categorize objects hierarchically (e.g., understanding that a golden retriever is simultaneously a dog and an animal) and arrange items quantitatively along a dimension (e.g., ordering sticks by length).

Limitation : The child still struggles with purely abstract, counterfactual, or hypothetical propositions that lack physical reality.

Formal Operational Stage (11 Years and Beyond) :

Core Mechanism : Development of abstract, idealistic, and hypothetical-deductive reasoning. Adolescents can systematically formulate and test hypotheses, evaluate counterfactual conditionals ("what if"), and use propositional logic.

Metacognition : Ability to reflect on one's own cognitive processes ("thinking about thinking"), accompanied by adolescent egocentrism (imaginary audience and personal fable).

Erik Erikson's Psychosocial Stages

Erikson conceptualized development as navigating eight sequential psychosocial crises across the lifespan, each resulting in a core psychological strength or vulnerability:

Developmental Stage Psychosocial Crisis Key Developmental Task Maladaptive Outcome Resulting Virtue

Infancy (0–18 months) Trust vs Mistrust Consistent, sensitive caregiving meets basic physiological and emotional needs Insecurity, acute hypervigilance, withdrawal Hope

Early Childhood (18m–3 years) Autonomy vs Shame & Doubt Developing physical autonomy (toileting, walking, feeding, choosing) Inadequacy, self-doubt, compulsive doubt Will

Preschool (3–6 years) Initiative vs Guilt Initiating motor play, exploring environment, asserting social leadership Excessive guilt, fear of punishment, inhibition Purpose

School Age (6–12 years) Industry vs Inferiority Mastering scholastic skills, peer sports, social rules, and hobbies Feelings of inadequacy, perceived failure, apathy Competence

Adolescence (12–18 years) Identity vs Role Confusion Developing coherent personal identity, values, sexual identity, career aspirations Identity diffusion, alienation, peer dependency Fidelity

Biological and Psychological Basis of Attachment Theory

Attachment theory , formulated by John Bowlby and operationalized by Mary Ainsworth, posits that human infants possess an innate evolutionary drive to seek proximity to a primary caregiver (attachment figure) to ensure physical protection and emotional regulation. Over the first year of life, interactions with the caregiver coalesce into internal cognitive representations—termed Internal Working Models —that dictate expectations regarding personal self-worth and the emotional trustworthiness of others. [Attachment Classification]

  • (Ainsworth Strange Situation)
  • |
  • +-----------------------------+-----------------------------+
  • | |
  • [Organised] [Disorganised]
  • | |
  • +-----------+-----------+ [Type D]
  • | | - Contradictory behaviors
  • [Secure] [Insecure] - Freezing, disorientation
  • (Type B) | - Caregiver is source
  • Explores freely +-------+-------+ of fear
  • Easily consoled | | - Trauma / severe neglect
  • [Avoidant] [Resistant/Ambivalent]
  • (Type A) (Type C)
  • Minimizes - Exaggerates distress
  • distress - Clingy yet resistant
  • Avoids - Difficult to soothe
  • reunion
  • Ainsworth's Strange Situation Protocol and Attachment Styles

Mary Ainsworth's standardized laboratory paradigm exposes infants aged 12 to 18 months to eight sequential episodes of brief separations and reunions with the primary caregiver in the presence of an unfamiliar adult observer. Based on reunion behaviors, four primary attachment patterns are recognized:

Secure Attachment (Type B; ~60–65% of community infants) :

Behavior : Infant uses the caregiver as a secure base from which to actively explore the environment. Shows visible distress upon separation. Upon reunion, the infant enthusiastically approaches the caregiver, seeks physical proximity, is rapidly and effectively soothed, and promptly resumes play.

Caregiver Characteristics : Consistent parental sensitivity, emotional warmth, prompt responsiveness to distress, and attuned mentalization.

Insecure-Avoidant Attachment (Type A; ~15–20% of infants) :

Behavior : Infant explores the environment without referencing the caregiver. Demonstrates little to no overt distress upon parental departure. Crucially, upon reunion, the infant actively avoids, turns away, or ignores the caregiver , maintaining proximity to toys. Physiological telemetry demonstrates that avoidant infants experience intense autonomic arousal (tachycardia and elevated salivary cortisol) despite their calm, detached exterior.

Caregiver Characteristics : Consistently rejecting, emotionally cold, or over-controlling parenting that discourages open displays of vulnerability.

Insecure-Resistant / Ambivalent Attachment (Type C; ~10–15% of infants) :

Behavior : Infant displays intense anxiety, clinging, and poverty of exploration even before separation. Becomes acutely devastated and inconsolable upon parental departure. Upon reunion, the infant displays a striking ambivalence: seeking physical proximity while simultaneously exhibiting angry resistance (kicking, pushing away, squirming out of arms). The infant cannot be soothed and fails to return to play.

Caregiver Characteristics : Inconsistent, unpredictable caregiving, where the parent alternates unpredictably between warm involvement and cold neglect, causing the infant to maximize emotional signals.

Disorganised / Disoriented Attachment (Type D; ~5–10% of community cohorts, up to 80% in maltreated populations) :

Behavior : Identified by Mary Main and Judith Solomon, infants lack a coherent behavioral coping strategy. Upon reunion, they display contradictory, disoriented, or apprehensive behaviors , such as freezing mid-motion, falling prone on the floor, rocking stereotypically, or approaching the caregiver with the head completely averted or backing away in terror.

Psychological Etiology : The caregiver is simultaneously the biological source of survival and the primary source of terror ("fright without solution").

Caregiver Characteristics : Severe physical abuse, profound neglect, domestic violence, parental substance dependence, or unaddressed parental trauma.

Toxic Stress and Adverse Childhood Experiences (ACEs)

Adverse Childhood Experiences (ACEs)—encompassing physical, emotional, or sexual abuse; emotional or physical neglect; and household dysfunction (maternal intimate partner violence, parental substance abuse, severe mental illness, incarceration, or parental separation)—exert profound, dose-dependent biological effects on child neurodevelopment.

Neurobiological Mechanisms of Toxic Stress :

Sustained activation of the sympatho-adrenomedullary (SAM) axis and hypothalamic-pituitary-adrenal (HPA) axis results in chronic hypercortisolemia and eventual blunting of normal diurnal cortisol rhythms.

Hippocampal Atrophy : Chronic glucocorticoid neurotoxicity and loss of brain-derived neurotrophic factor (BDNF) lead to reduced volume of the hippocampus, compromising episodic memory and emotional context processing.

Prefrontal Cortex (PFC) Impairment : Premature arrest of synaptogenesis and loss of dendritic branching in the PFC result in executive dysfunction, attention deficits, and impaired inhibitory impulse control.

Amygdala Hypertrophy and Hyper-reactivity : Hyper-innervation and dendritic expansion of the basolateral amygdala produce a persistent state of hypervigilance, emotional lability, and catastrophic threat appraisal.

Lifelong Morbidity : In Felitti et al.’s 1998 study, four or more ACE categories versus none were associated with adjusted odds ratios of 4.6 for depressed mood, 12.2 for a reported suicide attempt, 2.2 for ischaemic heart disease and 3.9 for chronic bronchitis or emphysema. These observational associations are population estimates, not an individual prognosis.

Validated Psychiatric Screening Instruments in Paediatric Practice

Paediatric primary care providers are positioned at the frontline of mental health detection. Validated screening can bring emotional and behavioural concerns to attention; positive results require clinical assessment rather than diagnosis by score alone. Standardized, validated multi-informant screening tools are indispensable.

Instrument Age Range Informants Domains Evaluated Clinical Scoring & Cut-offs

Strengths and Difficulties Questionnaire (SDQ) 2–17 years Parents, Teachers, Self-report (ages 11–17) 5 scales (5 items each): Emotional symptoms, Conduct problems, Hyperactivity/inattention, Peer problems, Prosocial behaviour Total Difficulties Score (0–40) = sum of 4 problem scales (prosocial excluded). Original UK parent 4–17-year band: ≥ 17 \ge 17 ≥ 17 is an abnormal/high screening result. Use age- and informant-specific bands and the Impact Supplement; confirm concerns clinically.

Pediatric Symptom Checklist (PSC-17 / PSC-35) 4–18 years Parents, Youth self-report (ages 11+) Broad-spectrum screen: Internalizing, Externalizing, Attention problems PSC-17 cut-off: Total score ≥ 15 \ge 15 ≥ 15 indicates positive screen. PSC-35 cut-off: ≥ 28 \ge 28 ≥ 28 (ages 6–18) indicates psychosocial dysfunction.

Patient Health Questionnaire Modified for Adolescents (PHQ-9A) 11–18 years Adolescent self-report DSM criteria for Major Depressive Disorder (depressed mood, anhedonia, sleep, appetite, energy, guilt, concentration, psychomotor, suicidal ideation) Scores: 5–9 mild, 10–14 moderate, 15–19 moderately severe, ≥ 20 \ge 20 ≥ 20 severe depression. Item 9 asks about death or self-harm thoughts ; a positive response needs prompt suicide-safety assessment. The PHQ-9A is a depression screen, not a validated suicide-risk screen.

Screen for Child Anxiety Related Disorders (SCARED) 8–18 years Child and Parent versions 41 items across 5 domains: Panic/somatic, Generalised anxiety, Separation anxiety, Social phobia, School avoidance Total score ≥ 25 \ge 25 ≥ 25 is a positive anxiety screen; higher subscale scores suggest domains for further clinical assessment.

  • Common Childhood Emotional Disorders
  • 1. Childhood Anxiety Disorders

Anxiety disorders represent the most common psychiatric morbidity of childhood, affecting 8 − 12 % 8-12\% 8 − 12% of youth.

Separation Anxiety Disorder :

Clinical Presentation : Developmentally inappropriate, severe anxiety concerning separation from attachment figures, persisting for at least 4 weeks in children/adolescents. Symptoms include unrealistic fears that harm will befall parents, refusal to sleep without being near an adult, nightmares with themes of separation, and intense distress on school mornings accompanied by somatic complaints (paroxysmal abdominal pain, nausea, headache) that resolve if the child is permitted to stay home.

Generalised Anxiety Disorder (GAD) :

Clinical Presentation : Chronic, pervasive, uncontrollable worry regarding multiple everyday domains (scholastic performance, punctuality, athletic competence, natural disasters, family finances). Manifests physically as restlessness, muscle tension, easy fatigability, sleep-onset insomnia, and perfectionism (erasing homework repeatedly, excessive need for reassurance).

Panic Disorder and Agoraphobia :

Clinical Presentation : Recurrent unexpected panic attacks—abrupt surges of intense fear peaking within minutes, accompanied by palpitations, diaphoresis, dyspnea, choking sensations, chest discomfort, dizziness, and derealization. In adolescents, it frequently triggers persistent anticipatory anxiety about future attacks or avoidance of places from which escape might be difficult (agoraphobia).

Social Anxiety Disorder (Social Phobia) :

Clinical Presentation : Marked, persistent fear of social or performance situations involving peers (not merely unfamiliar adults). The child fears negative evaluation, embarrassment, or humiliation, leading to selective mutism in school, avoidance of oral presentations, and school absenteeism.

  • 2. Major Depressive Disorder (MDD) in Children and Adolescents [Paediatric Depression: Core Manifestations]
  • |
  • +-------------------+---------------+-------------------+-------------------+
  • | | | | |
  • [Irritability &] [Somatic Focus] [Academic Decline] [Anhedonia &] [Suicidality &
  • Affective (Headaches, (Loss of executive Boredom Self-Harm]
  • Reactivity abdominal concentration) (Social withdrawal) (Mandatory risk
  • (Mood lability) cramping) stratification)

Developmentally Distinct Presentation :

Unlike adults who display pervasive melancholic or depressed mood, depressed children and adolescents frequently present with persistent irritability, grouchiness, temper outbursts, and affective reactivity (briefly cheering up during desirable activities).

Prominent somatic complaints (vague gastrointestinal distress, recurrent headaches) without medical etiology.

Unexplained academic deterioration, anhedonia described as "constant boredom," hypersomnia or sleep reversal, changes in appetite, and withdrawal from peer groups.

Stepped-Care Management Paradigm :

Mild Depressive Episodes : Under NICE guidance, provide support and active monitoring, with reassessment normally within 2 weeks if watchful waiting is chosen. Offer psychological therapy for continuing depression; antidepressants are not initial treatment.

Moderate to Severe Depressive Episodes : First-line intervention is structured, evidence-based psychotherapy: Cognitive Behavioural Therapy (CBT) or Interpersonal Psychotherapy for Adolescents (IPT-A) .

Pharmacological Intervention : After child and adolescent psychiatric assessment, consider fluoxetine with psychological therapy for moderate/severe depression at ages 12–18, either initially or after inadequate response to therapy. Younger children need cautious specialist review; unavailable therapy alone is not a prescribing indication.

Fluoxetine : NICE’s first-choice antidepressant for paediatric depression; UK licensing covers ages 8–18 with psychological therapy after inadequate psychological-treatment response. FDA depression approvals include fluoxetine from age 8 and escitalopram from age 12. NICE dosing starts at 10 mg/day 10\ \text{mg/day} 10 mg/day and may increase to 20 mg/day 20\ \text{mg/day} 20 mg/day after 1 week if necessary; higher doses require specialist judgement.

NICE second-line options after specialist review are sertraline or citalopram if fluoxetine fails or is not tolerated; licensing and alternative national pathways differ.

Avoid for Paediatric Depression : NICE advises against paroxetine because the evidence does not show a favourable balance of benefit and harm.

Regulatory Black-Box Warning and Clinical Surveillance : In the USA, antidepressants carry a boxed warning regarding an increased risk of treatment-emergent suicidal thoughts and behaviors in children, adolescents, and young adults ( < 25 <25 < 25 years; risk difference of approximately 1 − 2 % 1-2\% 1 − 2% over placebo without completed suicides in clinical trials). Symptoms of behavioral activation, agitation, motor restlessness (akathisia), insomnia, and disinhibition peak during the first 4 to 6 weeks of therapy or following dose increases. Arrange frequent clinical contact, particularly early and after dose changes. NICE gives weekly contact for the first 4 weeks as an example; agree and document the frequency for the individual patient.

  • Paediatric Psychiatric Emergencies
  • 1. Acute Suicidal Crisis

Triage and Risk Stratification : Immediate assessment must evaluate suicidal intent, specificity and lethality of the proposed plan, availability of lethal means, history of prior suicide attempts, co-occurring substance intoxication, and protective factors (family support, future orientation).

Immediate Safety Actions : Implement immediate, non-negotiable lethal means restriction (safely securing or removing all household firearms, prescription medications, over-the-counter analgesics like paracetamol, sharp implements, and ligature points). "No-suicide contracts" are clinically ineffective and should be replaced by a collaborative Crisis Safety Plan identifying personal warning signs, internal coping mechanisms, supportive social contacts, and emergency crisis telephone contacts.

Disposition : Inpatient psychiatric hospitalization is indicated for active suicidal intent, unmanageable agitation, persistent psychosis, or an unsafe, unsupportive domestic environment.

2. Deliberate Non-Suicidal Self-Injury (NSSI)

Definition : Direct, deliberate destruction of body tissue without conscious suicidal intent, most frequently manifesting as superficial skin cutting, burning, severe scratching, or banging head/limbs.

Psychological Function : Operates as a maladaptive, rapid mechanism for affect regulation —terminating unbearable negative emotional tension, relieving intense guilt or numbness (dissociation), or communicating distress. It must be clinically differentiated from true suicidal attempts, although chronic NSSI confers an elevated longitudinal risk for future suicidal behavior.

Management : Dialectical Behaviour Therapy for Adolescents (DBT-A) is the gold-standard treatment, targeting emotion regulation, distress tolerance, and interpersonal effectiveness.

3. Acute Psychosis in Children and Adolescents

True early-onset schizophrenia ( < 13 <13 < 13 years) is exceedingly rare ( < 1 <1 < 1 in 30 , 000 30,000 30 , 000 ). In children and adolescents presenting with acute hallucinations, delusions, catatonia, or formal thought disorder, assess medical, neurological and substance-related causes through history and examination. Choose investigations according to the clinical findings; the following differential is not a routine panel for every psychiatric presentation.

Etiological Category Organic Disorder Key Clinical Features Investigations When the Disorder Is Suspected

Autoimmune Encephalitis Anti-NMDA Receptor Encephalitis Acute behavioral change, visual/auditory hallucinations, insomnia, followed by seizures, movement disorders (orofacial dyskinesias, chorea), autonomic instability, central hypoventilation Serum and CSF anti-GluN1 (NMDA receptor) antibodies; Pelvic MRI or ultrasound (screening for ovarian teratoma in females); Brain MRI; Continuous EEG

Metabolic / Heavy Metal Wilson Disease (Hepatolenticular Degeneration) Personality changes, psychosis, declining school performance, dysarthria, resting tremor, dystonia, hepatic dysfunction Serum ceruloplasmin ( < 20 mg/dL <20\ \text{mg/dL} < 20 mg/dL ); 24-hour urinary copper excretion ( > 100 μ g/24h >100\ \mu\text{g/24h} > 100 μ g/24h ); Slit-lamp exam for Kayser-Fleischer rings; Liver function tests

Autoimmune / Rheumatic Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Acute confusional state, psychosis, lupus cerebritis, mood disorder, accompanied by malar rash, nephritis, arthritis Antinuclear antibodies (ANA), anti-dsDNA, anti-Smith, anti-ribosomal P antibodies; Serum complement levels (C3, C4); Brain MRI with contrast

Inborn Errors of Metabolism Late-Onset Urea Cycle Disorders / Porphyria Episodic psychosis, encephalopathy, ataxia triggered by high protein intake or catabolic stress (OTC deficiency); or severe abdominal pain, peripheral neuropathy (Acute Intermittent Porphyria) Plasma ammonia; Plasma amino acids (citrulline, arginine); Urine organic acids (orotic acid); Urine porphobilinogen (PBG) and aminolevulinic acid (ALA)

Toxic / Pharmacological Substance Ingestion / Drug Toxicity Acute onset hallucinations (often visual or tactile), dilated pupils, tachycardia, bizarre agitation, paranoia (synthetic cannabinoids, bath salts, PCP, MDMA, anticholinergic toxicity, high-dose corticosteroids) Comprehensive urine and serum toxicology screen via liquid chromatography-tandem mass spectrometry (LC-MS/MS); Serum electrolytes, CK, and ethanol level